Dr. Kane has more than 30 years of experience in the science and business of taking molecules through the entire drug development process. His extensive knowledge spans early stage development to scale-up and commercial manufacturing of drug products and includes technical transfers between global sites and drug life cycle management.
Dr. Kane received his Bachelors, Masters and Ph.D. degrees from the Bombay College of Pharmacy, University of Bombay, India, and served as a post-doctoral fellow at the School of Pharmacy, University of Cincinnati, Ohio. He has also earned an executive MBA from Richard Ivey School of Business, University of Western Ontario, Canada. Dr. Kane is a member of various international pharmaceutical professional organizations and is a speaker at many industry events. He has also published many articles in International journals and delivered many talks at meetings and conferences cross the globe.
Dawn Williams, Executive Director, based in UK. Dawn has been in clinical research for 24 years in both academic and industry setting, spending most of her career with Fortrea. During her time at Fortrea, she has specialised in FSP across multiple biopharma sponsors of varying size, from small to large partnerships, leveraging a diverse range of FSP models.
Neil Vande Bunte is the Director of Technology & Innovation Investment at Invest Alberta. He supports companies expanding into Alberta’s economy, with a focus on data centers and AI infrastructure, connecting investors with the partners, information, and sites they need to succeed.
Neil previously spent many years in the oil and gas service sector in leadership roles across four continents, before moving into tech and innovation in 2020, where he led the Southern Alberta region for a non profit funding early stage startups and launched an Agri Food investment program across the Prairies.
Rooted in Alberta, Neil was born and raised in rural Alberta and now lives in Calgary with his family.
Pablo Seijo is a data-driven sales executive with over 10 years of international experience across SaaS, marketplaces, logistics, and hospitality technology. He has led commercial growth in high-scale environments, including launching new markets and driving global sales operations.
As VP of Sales at STAY, Pablo leads revenue growth for a guest experience platform used by enterprise hotel groups worldwide. He focuses on building repeatable sales playbooks, scaling high-performance teams, and applying analytical rigor to solve complex commercial challenges.
Joan Lladó is the Founder and CEO of STAY. Together with his brother, Angel Lladó, he founded the company with the vision of transforming how hotels engage with guests through digital experiences that reduce operational friction and drive measurable business impact.
Under his leadership, STAY has grown into a global guest experience platform used by enterprise hotel groups in more than 70 countries. Joan brings a strong product-driven mindset, deep hospitality knowledge, and a long-term focus on building scalable technology tailored to the real needs of hotel chains. This approach positions STAY as a long-term partner for hotel groups looking to elevate the guest experience and strengthen their brand at scale.
April Bell, MS, CCRC, ACRP-PM, is an accomplished clinical research professional with over two decades of experience in managing and conducting complex clinical trials across diverse therapeutic areas. Currently serving as Manager of Clinical Research Operations at JPS Health Network in Fort Worth, Texas, she oversees research activities across multiple clinical therapeutic specialties.
Jim Routt is Chief Operating Officer of IQVIA Biotech, overseeing end‑to‑end project delivery for biotech and emerging biopharma sponsors. He brings 23+ years of industry experience, with deep expertise in oncology clinical development, having previously led the global oncology delivery organization across programs, customers and strategic partnerships. His leadership is grounded in a strong commitment to quality, compliance and patient safety, with a clear focus on delivering meaningful value to customers and improving outcomes for patients worldwide.
